Soleno Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Soleno Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Soleno Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Soleno Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $190M | 2.8M | 67.60 |
| 2025-06-30 | $208M | 2.5M | 83.78 |
| 2025-03-31 | $133M | 1.9M | 71.45 |
| 2024-12-31 | $85M | 1.9M | 44.95 |
| 2024-09-30 | $80M | 1.6M | 50.49 |
| 2024-06-30 | $61M | 1.5M | 40.80 |
| 2024-03-31 | $42M | 970k | 42.80 |
| 2023-12-31 | $39M | 970k | 40.25 |
| 2023-09-30 | $1.6M | 55k | 29.51 |
| 2023-06-30 | $214k | 50k | 4.29 |
| 2023-03-31 | $107k | 50k | 2.14 |
| 2022-12-31 | $99k | 50k | 1.98 |